DSN recently caught up with Sajid Syed, president of Acro Pharmaceutical Services, to talk about how the company works with what he calls the "four P's" — the patient, physician, pharmaceutical manufacturer and payer — to provide an array of specialty pharmacy services to clients.
“A profound, and likely irreversible, impact on the business of health care.” That’s the effect the Patient Protection and Affordable Care Act already has had in the five years since its passage and enactment into law, PricewaterhouseCoopers said.
TruTag Technologies is looking to impact the food and drug industry with its edible security platform. “TruTags,” the company's microtags, can help to authenticate products without packaging or labels. DSN recently spoke with Kent Mansfield, president of TruTag Technologies.
Navy vet Jon Giacomin, CEO of the pharmaceutical segment at Cardinal Health, presented a “Quilt of Valor” to Jeremiah Pauley, Warriors Speak spokesperson, at the Cardinal Health Retail Business Conference.
Thousands of independent pharmacy owners from across the country gathered here last month for McKesson ideaShare 2015, to explore the latest tools and strategies to help enhance patient care and improve profitability.
The focus on education at McKesson’s ideaShare 2015 didn’t stop when the exhibit hall opened Thursday evening. Friday and Saturday in San Diego saw a robust lineup of Continuing Education and Lunch & Learn sessions that aimed to keep independent pharmacy owners and pharmacists apprised of the latest developments in patient care and the current state of the business.
Mergers and acquisitions among pharmaceutical companies has kicked into high gear this year, mirroring the larger trend sweeping across the entire spectrum of the health care industry since the implementation of the Affordable Care Act two years ago.
While building a 4,500-store retail pharmacy powerhouse in the United States, Walmart also has kept pace with the specialty pharmacy revolution and is positioning itself to play a stronger role in this most innovative, dynamic and complex area of pharmaceutical R&D and bioengineering.